You Lu Selected Research

Exanthema (Rash)

4/2023	Immunotherapy for non-small cell lung cancer with EGFR or HER2 exon 20 insertion mutations: a real-world analysis.
1/2022	AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
3/2020	Long-term safety of icotinib in patients with non-small cell lung cancer: a retrospective, real-world study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

You Lu Research Topics

Disease

81	Neoplasms (Cancer) 12/2023 - 02/2002
75	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 09/2008
29	Neoplasm Metastasis (Metastasis) 09/2023 - 06/2009
20	Lung Neoplasms (Lung Cancer) 03/2023 - 05/2010
15	Disease Progression 01/2023 - 08/2013
10	Inflammation (Inflammations) 01/2024 - 12/2010
10	Adenocarcinoma of Lung 01/2021 - 08/2009
8	Brain Neoplasms (Brain Tumor) 12/2020 - 03/2014
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 08/2013
6	Esophageal Neoplasms (Esophageal Cancer) 04/2023 - 07/2010
6	Diarrhea 01/2022 - 10/2018
6	Esophageal Squamous Cell Carcinoma 01/2020 - 09/2009
6	Lung Injury 11/2017 - 08/2010
5	Radiation Pneumonitis 01/2022 - 12/2010
5	Carcinoma (Carcinomatosis) 01/2020 - 07/2009
5	Hypoxia (Hypoxemia) 10/2018 - 08/2009
4	Carcinogenesis 01/2023 - 06/2009
4	Pneumonia (Pneumonitis) 01/2022 - 08/2013
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 08/2009
4	Infections 01/2022 - 12/2008
3	Exanthema (Rash) 04/2023 - 03/2020
3	Neutropenia 01/2022 - 08/2015
3	Hand-Foot Syndrome 01/2022 - 01/2018
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2015
3	Breast Neoplasms (Breast Cancer) 12/2021 - 05/2013
3	Colonic Neoplasms (Colon Cancer) 12/2021 - 02/2013
3	Lymphoma (Lymphomas) 12/2021 - 07/2014
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 03/2010
3	Nausea 03/2021 - 08/2015
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2013
3	Hypertension (High Blood Pressure) 01/2020 - 01/2015
3	Fibrosis (Cirrhosis) 01/2018 - 05/2011
3	Lewis Lung Carcinoma 08/2017 - 06/2009
3	Lymphatic Metastasis 01/2014 - 06/2009
2	Epilepsy (Aura) 09/2023 - 05/2019
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 09/2023 - 12/2022
2	Body Weight (Weight, Body) 08/2023 - 07/2017
2	Insulin Resistance 08/2023 - 01/2017
2	Obesity 01/2023 - 01/2021
2	Drug-Related Side Effects and Adverse Reactions 08/2022 - 03/2020
2	Hyperlipidemias (Hyperlipidemia) 08/2022 - 01/2015
2	Stroke (Strokes) 01/2022 - 01/2015
2	Pancreatitis 01/2022 - 11/2019
2	Kidney Neoplasms (Kidney Cancer) 12/2021 - 04/2015
2	Vomiting 03/2021 - 12/2020
2	Anemia 03/2021 - 10/2018

Drug/Important Bio-Agent (IBA)

22	ErbB Receptors (EGF Receptor)IBA 04/2024 - 03/2003
19	Tyrosine Kinase InhibitorsIBA 09/2023 - 10/2011
15	Immune Checkpoint InhibitorsIBA 04/2024 - 07/2015
10	Proteins (Proteins, Gene)FDA Link 08/2023 - 10/2008
8	Gefitinib (Iressa)FDA Link 01/2023 - 01/2012
8	PlatinumIBA 03/2022 - 10/2012
7	CrizotinibIBA 12/2020 - 07/2014
6	Pemetrexed (MTA)FDA Link 01/2022 - 10/2012
6	LigandsIBA 01/2021 - 02/2002
6	Liposomes (Liposome)IBA 06/2015 - 10/2008
5	CytokinesIBA 01/2023 - 02/2013
5	Anaplastic Lymphoma KinaseIBA 08/2022 - 07/2014
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2014
5	MicroRNAs (MicroRNA)IBA 12/2021 - 11/2013
5	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 07/2015 - 07/2009
5	VaccinesIBA 11/2007 - 02/2002
4	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 05/2013
4	anlotinibIBA 04/2023 - 01/2018
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 01/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2015
4	Phosphotransferases (Kinase)IBA 01/2022 - 07/2014
4	Bevacizumab (Avastin)FDA Link 01/2019 - 07/2015
4	Interleukin-6 (Interleukin 6)IBA 10/2018 - 04/2015
3	osimertinibIBA 09/2023 - 05/2019
3	Long Noncoding RNAIBA 08/2023 - 01/2022
3	icotinibIBA 01/2023 - 01/2016
3	Docetaxel (Taxotere)FDA Link 03/2022 - 01/2019
3	NivolumabIBA 03/2022 - 01/2019
3	Histones (Histone)IBA 01/2022 - 03/2010
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2021 - 12/2020
3	Alanine Transaminase (SGPT)IBA 03/2021 - 12/2020
3	endostar proteinIBA 03/2018 - 08/2009
3	AutoantibodiesIBA 06/2003 - 02/2002
2	CateninsIBA 01/2024 - 04/2019
2	Insulin (Novolin)FDA Link 08/2023 - 07/2017
2	Messenger RNA (mRNA)IBA 03/2023 - 01/2018
2	sugemalimabIBA 01/2023 - 01/2022
2	EnzymesIBA 01/2023 - 01/2011
2	C-Reactive ProteinIBA 01/2022 - 01/2015
2	aumolertinibIBA 01/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2011
2	Lipocalin-2IBA 04/2021 - 01/2021
2	ceritinibIBA 03/2021 - 12/2020

Therapy/Procedure

48	Radiotherapy 12/2023 - 01/2008
39	Therapeutics 10/2023 - 02/2002
28	Drug Therapy (Chemotherapy) 01/2023 - 10/2012
10	Immunotherapy 04/2024 - 11/2007
8	Chemoradiotherapy 01/2023 - 06/2010
4	Precision Medicine 01/2022 - 01/2017
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 05/2014 - 07/2010
3	Adjuvant Radiotherapy 01/2020 - 04/2013
2	Neoadjuvant Therapy 04/2023 - 01/2023
2	Sutures (Suture) 11/2021 - 01/2019